BioResolve SEC mAb Guard Columns for Production Process and Formulation Development Samples

Importance of the Topic

Size exclusion chromatography is a key technique for assessing the aggregation and fragmentation of biotherapeutic proteins. In manufacturing and formulation development, samples may contain particulate matter or precipitates that can rapidly degrade column performance. Implementing a protective guard column can prolong analytical column life, maintain resolution, and support high sample throughput during process development and quality control.

Study Objectives and Overview

This application brief evaluates the BioResolve SEC mAb Guard Column (2.5 µm, 200 Å) to protect a BioResolve SEC mAb analytical column (7.8 x 300 mm, 2.5 µm) from fouling by precipitated proteins. A comparison is made with an ACQUITY Protein BEH UPLC SEC guard (1.7 µm, 200 Å) to gauge relative tolerance to sample particulates.

Methodology and Workflow

Precipitated protein standards were generated by heating a BEH200 SEC protein mix at 80 °C for 30 minutes. Cetuximab in its commercial formulation (2 mg/mL) served as the model analyte. Injections of stressed standard and cetuximab were performed on an H Class Bio UPLC system with Empower 3 software. Analytical separations used a mobile phase of 50 mM sodium phosphate and 200 mM KCl at pH 7.0, with a flow rate of 0.575 mL/min.

Used Instrumentation

• Waters H Class Bio UPLC system equipped with Empower 3 data software
• BioResolve SEC mAb Guard Column, 2.5 µm particle size, 200 Å pore size
• BioResolve SEC mAb analytical column, 7.8 x 300 mm, 2.5 µm, 200 Å
• ACQUITY Protein BEH UPLC SEC Guard, 4.6 x 30 mm, 1.7 µm, 200 Å

Main Results and Discussion

Initial comparison showed negligible impact on HMWS resolution and only a slight decrease in monomer peak shape when using the 2.5 µm guard. After 40 injections of stressed protein, the guard column exhibited a gradual loss in HMWS resolution and increased monomer tailing. Replacing the guard restored most of the original chromatographic performance. In parallel, a 1.7 µm guard fouled more rapidly under similar challenge injections, demonstrating that larger particle size guard columns are less prone to clogging by suspended particulates.

Benefits and Practical Applications

• Extended lifetime of analytical SEC columns when analyzing samples with possible precipitates
• Maintained resolution for high molecular weight and low molecular weight species
• Supports high throughput in-process testing and formulation development
• Reduced maintenance and downtime due to fewer column replacements

Future Trends and Opportunities

Advances in guard column media and packing technology may further enhance resistance to fouling while preserving resolution. Integration with automated sample prep methods such as inline filtration or centrifugation could mitigate particulate challenges. The development of even more robust SEC phases for ultra-performance systems remains an active research area.

Conclusion

The BioResolve SEC mAb Guard Column effectively shields the analytical SEC column from precipitated proteins with minimal resolution loss and can be easily replaced to restore performance. The 2.5 µm particle size format shows superior tolerance to sample particulates compared to a 1.7 µm guard, making it a valuable choice for biotherapeutic process and formulation studies.

References

1. Roberts CJ. Therapeutic Protein Aggregation Mechanisms Design and Control Trends in Biotechnology 2014 32 7 372-380
2. Hong P Koza S Bouvier ES. Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates J Liq Chromatogr Relat Technol 2012 35 20 2923-2950
3. Philo JS. Is Any Measurement Method Optimal for All Aggregate Sizes and Types The AAPS Journal 2006 8 3 E564-E571
4. Mou X Yang X Li H Pollard DJ. A High Throughput Ultra Performance Size Exclusion Chromatography Assay for the Analysis of Aggregates and Fragments of Monoclonal Antibodies Pharmaceutical Bioprocessing 2014 2 2 141-156
5. Koza SM Reed C Chen W. Impact of LC System Dispersion on the Size-Exclusion Chromatography Analysis of Monoclonal IgG Antibody Aggregates and Fragments Waters Application Note 720006336EN 2018
6. Koza SM Reed C Chen W. Selecting the Optimal Column Configuration for Your Method Waters Application Note 720006336EN 2019
7. Koza SM Reed C Chen W. Evaluating the Impact of LC System Dispersion on the Size-Exclusion Chromatography Analysis of Proteins Waters Application Note 720006337EN 2019